Related Experiment Videos
HeartMate left ventricular assist device for long-term circulatory support
1Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Summary
Left ventricular assist devices (LVADs) offer safe, long-term circulatory support for end-stage heart failure patients. This study shows LVADs can improve cardiac output and allow patient recovery or bridge to transplant.
Area of Science:
- Cardiology
- Mechanical Circulatory Support
Background:
- End-stage heart failure presents significant challenges for long-term survival.
- Left ventricular assist devices (LVADs) are crucial for mechanical circulatory support.
- Postpartum and dilated cardiomyopathies are common causes of severe heart failure.
Observation:
- Three patients with end-stage heart failure (postpartum and dilated cardiomyopathy) in cardiogenic shock received HeartMate LVADs.
- Temporary support with intra-aortic balloon pump or extracorporeal membrane oxygenation (ECMO) was utilized.
- Vascutek grafts and ECMO were employed as a bridge strategy to mitigate bleeding and right ventricular failure risks associated with LVAD implantation.
Findings:
- Successful HeartMate LVAD implantation provided stable long-term circulatory support.
- Significant increases in cardiac output were observed post-implantation (from 2.06-2.70 L/min to 4.50-5.80 L/min).
- LVAD support was achieved without the need for anticoagulation, and patients remained ambulatory.
Implications:
- HeartMate LVADs offer a safe and effective option for long-term circulatory support in severe heart failure.
- LVADs can facilitate patient recovery, enable discharge, and serve as a bridge to heart transplantation.
- Long-term ventricular unloading may promote recovery of native heart function.